Immunization by particle bombardment of antigen-loaded poly-(DL-lactide-co-glycolide) microspheres in mice. (Q51304085)

3 April 2018

title

Immunization by particle bombardment of antigen-loaded poly-(DL-lactide-co-glycolide) microspheres in mice. (English)

1 reference

3 April 2018

0 references

1 reference

Masaki Uchida

1

1 reference

3 April 2018

Hideshi Natsume

2

1 reference

3 April 2018

Tohru Kishino

3

1 reference

3 April 2018

Toshinobu Seki

4

1 reference

3 April 2018

Masahiko Ogihara

5

1 reference

3 April 2018

Kazuhiko Juni

6

1 reference

3 April 2018

Masayuki Kimura

7

1 reference

3 April 2018

Yasunori Morimoto

8

1 reference

3 April 2018

language of work or name

English

0 references

publication date

28 November 2005

1 reference

3 April 2018

published in

Vaccine

1 reference

3 April 2018

volume

24

1 reference

3 April 2018

issue

12

1 reference

3 April 2018

page(s)

2120-2130

1 reference

3 April 2018

Epitope-vaccine as a new strategy against HIV-1 mutation

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.027

Identification and characterization of the neutralization epitope(s) of the hepatitis E virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.027

DNA vaccination strategies against infectious diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.027

Vaccines and vaccine strategies against HIV.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.027

7 January 2021

Therapeutic HIV Vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.027

Influenza virus: immunity and vaccination strategies. Comparison of the immune response to inactivated and live, attenuated influenza vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.027

Novel generations of influenza vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.027

7 January 2021

Influenza DNA vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.027

DNA vaccines against cancer: from genes to therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.027

7 January 2021

Antigen delivery systems

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.027

Future vaccines and a global perspective

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.027

Biodegradable microspheres as a vaccine delivery system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.027

Effect of the size and surface charge of polymer microspheres on their phagocytosis by macrophage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.027

Protein precoating of polylactide microspheres containing a lipophilic immunopotentiator for enhancement of macrophage phagocytosis and activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.027

Biodegradable microparticles for oral immunization.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.027

Synthetic peptides entrapped in microparticles can elicit cytotoxic T cell activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.027

Transcutaneous immunization: a human vaccine delivery strategy using a patch

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.027

Adjuvantation of epidermal powder immunization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.027

The skin immune system Its cellular constituents and their interactions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.027

Introduction of poly-L-lactic acid microspheres into the skin using supersonic flow: effects of helium gas pressure, particle size and microparticle dose on the amount introduced into hairless rat skin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.027

Effects of particle size, helium gas pressure and microparticle dose on the plasma concentration of indomethacin after bombardment of indomethacin-loaded poly-L-lactic acid microspheres using a Helios gun system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.027

The encapsulation of a model protein in poly (D, L lactide-co-glycolide) microparticles of various sizes: an evaluation of process reproducibility

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.027

Optimization of Preparative Conditions for Polylactide (PLA) Microspheres Containing Ovalbumin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.027

Oral immunization of rainbow trout with antigen microencapsulated in poly(DL-lactide-co-glycolide) microparticles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.027

Ovalbumin peptide encapsulated in poly(d,l lactic-co-glycolic acid) microspheres is capable of inducing a T helper type 1 immune response.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.027

Introduction of DNA into rat liver with a hand-held gene gun: distribution of the expressed enzyme, [32P]DNA, and Ca2+ flux

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.027

Long-term antibody responses in mice following subcutaneous immunization with ovalbumin entrapped in biodegradable microparticles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.027

Controlled release microparticles as a single dose hepatitis B vaccine: evaluation of immunogenicity in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.027

In vivo uptake of an experimental microencapsulated diphtheria vaccine following sub-cutaneous immunisation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.027

Role of cytokines and CD4+ T-cell subsets in the regulation of parasite immunity and disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.027

A TH1-->TH2 switch is a critical step in the etiology of HIV infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.027

Cytokine patterns during the progression to AIDS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.027

Teaching the immune system to fight cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.027

Serum and mucosal immune responses to an inactivated influenza virus vaccine induced by epidermal powder immunization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.027

Immunogenicity and protection in small-animal models with controlled-release tetanus toxoid microparticles as a single-dose vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.027

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2005.11.027

1 reference

3 April 2018

1 reference

3 April 2018